ArticleJournal of experimental & clinical cancer research : CR2025

Antibody-based delivery of interleukin-2 modulates the immunosuppressive tumor microenvironment and achieves cure in pancreatic ductal adenocarcinoma syngeneic mice.

Carmine Carbone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.